2021
Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions
Harrigan M, McGowan C, Hood A, Ferrucci LM, Nguyen T, Cartmel B, Li FY, Irwin ML, Sanft T. Dietary Supplement Use and Interactions with Tamoxifen and Aromatase Inhibitors in Breast Cancer Survivors Enrolled in Lifestyle Interventions. Nutrients 2021, 13: 3730. PMID: 34835986, PMCID: PMC8621720, DOI: 10.3390/nu13113730.Peer-Reviewed Original ResearchConceptsBreast cancer survivorsDietary supplement useCancer survivorsAromatase inhibitorsSupplement useDietary supplementsEndocrine therapyLifestyle interventionWorld Cancer Research Fund/American InstituteSelf-reported dietary supplement useNatural Medicines databaseAdjuvant endocrine therapyBreast cancer treatmentAdverse interactionsPotential adverse interactionsPharmacodynamic interactionsClinical efficacyCancer preventionHigh prevalenceGeneral populationPotential interactionsMedicine DatabaseTamoxifenCancer treatmentSurvivors
2015
Three-Dimensional Evaluation of Aortic Valve Annular Shape in Children With Bicuspid Aortic Valves and/or Aortic Coarctation Compared With Controls
Chamberland CR, Sugeng L, Abraham S, Li F, Weismann CG. Three-Dimensional Evaluation of Aortic Valve Annular Shape in Children With Bicuspid Aortic Valves and/or Aortic Coarctation Compared With Controls. The American Journal Of Cardiology 2015, 116: 1411-1417. PMID: 26375172, DOI: 10.1016/j.amjcard.2015.07.063.Peer-Reviewed Original ResearchConceptsBicuspid aortic valveEccentricity indexAortic valveAnnular dimensionsAV annulusControl groupCommon congenital cardiac abnormalityCoA groupDegenerative aortic valve diseaseEchocardiograms of childrenAortic valve diseaseBody surface areaCongenital cardiac abnormalitiesAV dysfunctionValve dysfunctionNoncoronary cuspAortic annulusAortic coarctationThree-dimensional evaluationValve diseaseInterventional resultsGeneral populationNormal controlsCardiac abnormalitiesAnnular size